We surveyed U.S. reinsurers regarding their practices and viewpoints
about use of the NT-proBNP cardiac test by their clients. The report of this survey will be of keen interest to insurers using (or contemplating the use of) NT-proBNP.
This paper aims to provide what underwriters and claims examiners need to know about this ever-expanding aggregation of synthetic drugs that are luring users with their enhanced Cannabis-like effects.
